Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

LFCR holding history

Lifecore Biomedical, Inc. in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LFCR overviewAll 13F holders of LFCRFull Q2 2026 holdings

Shares (Q2 2026)
7,935
Value
$41.7K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of LFCR by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,935$41.7K<0.1%−929−10.5%ReducedHolders
Q1 20268,864$33.0K<0.1%−37,832−81.0%ReducedHolders
Q4 202546,696$382.0K<0.1%+6,124+15.1%AddedHolders
Q3 202540,572$298.6K<0.1%−7,203−15.1%ReducedHolders
Q2 202547,775$387.9K<0.1%+22,321+87.7%AddedHolders
Q1 202525,454$179.2K<0.1%−8,518−25.1%ReducedHolders
Q4 202433,972$252.4K<0.1%+4,028+13.5%AddedHolders
Q3 202429,944$147.6K<0.1%+22,489+301.7%AddedHolders
Q2 20247,455$38.2K<0.1%+7,455NewHolders
Q1 20240$00.0%−19,508−100.0%Sold outHolders
Q4 202319,508$120.8K<0.1%−11,403−36.9%ReducedHolders
Q3 202330,911$233.2K<0.1%+21,946+244.8%AddedHolders
Q2 20238,965$86.7K<0.1%+8,917+18,577.1%AddedHolders
Q1 202348$181<0.1%−8,136−99.4%ReducedHolders
Q4 20228,184$53.0K<0.1%+6,992+586.6%AddedHolders
Q3 20221,192$11.0K<0.1%−121−9.2%ReducedHolders
Q2 20221,313$13.0K<0.1%−2,933−69.1%ReducedHolders
Q1 20224,246$49.0K<0.1%−28,485−87.0%ReducedHolders
Q4 202132,731$363.0K<0.1%+21,055+180.3%AddedHolders
Q3 202111,676$108.0K<0.1%−4,312−27.0%ReducedHolders
Q2 202115,988$180.0K<0.1%−18,299−53.4%ReducedHolders
Q1 202134,287$363.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.